ArticleCell reports. Medicine2026
Pan-cancer analysis of spatial transcriptomics reveals heterogeneous tumor spatial microenvironment.
Article in Cell reports. Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Spatial ecotype in tumor immune exclusion: from spatial architecture to therapeutic strategies.Molecular cancer · 2026Review
- Spatial Transcriptomics Recontextualizes the Cellular Environment of Conjunctival Melanoma.medRxiv : the preprint server for health sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tumors are complex systems comprising diverse cell types that form the tumor spatial microenvironment (TSME). We present a pan-cancer spatial transcriptomic analysis of 373 samples across 12 cancer types and identify 56 local cellular programs (LCPs) and 13 recurrent niches. Ligand-receptor analysis reveals niche-shared and niche-specific interactions that drive spatial organization. Notably, gene expression in tumor cells and macrophages depends heavily on their specific location. Furthermore, niches associate significantly with clinical outcomes: macrophages colocalized with tumor cells (Niche_4) correlate with poor prognosis and immunotherapy resistance, while those colocalized with immune cells (Niche_11) predict better survival and treatment response. This systematic dissection of the TSME provides deeper insights into cellular communication and the structural influences governing complex tumor ecosystems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.